Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1389-1393

  Wu, Pingping ^a,b,c   Jin, Juan ^a,b,c   Everly, Matthew J ^d   Lin, Chuan ^a,b,c   Terasaki, Paul I ^d   Chen, Jianghua ^a,b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b Kidney Disease Immunology Laboratory   (China)

^c Zhejiang Province Key Laboratory of Biofuel   (China)

^d TERASAKI FOUNDATION LABORATORY   (United States)

Author keywords

Anti HLA antibodies; Antibody mediated rejection; Donor specific antibodies; Kidney transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE;

AMR; ANTI-HLA ANTIBODIES; ANTIBODY MEDIATED REJECTION; ANTIBODY-MEDIATED REJECTION; CDC-XM; CELL MEDIATED REJECTION; CMR; COMPLEMENT DEPENDENT CYTOTOXICITY CROSSMATCH; DONOR SPECIFIC ANTIBODY; DONOR-SPECIFIC ANTIBODIES; DSA; FLOW CROSSMATCH; FXM; KIDNEY TRANSPLANTATION; MEAN FLUORESCENCE INTENSITY; MFI; PERITUBULAR CAPILLARIES; PTC; SAFB; SINGLE ANTIGEN FLOW BEAD;

ADOLESCENT; ADULT; AGED; ANTIBODY AFFINITY; BIOLOGICAL MARKERS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TISSUE DONORS;

EID: 84884352996     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.05.053     Document Type: Article

References (21)

1. Terasaki P.I., Kreisler M., Mickey R.M. Presensitization and kidney transplant failures. Postgrad Med J 1971, 47(544):89.
2. Patel R., Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969, 280(14):735.
3. Cook D.J., Terasaki P.I., Iwaki Y., Terashita G., Takeda A., Fujikawa J., et al. The flow cytometry crossmatch in kidney transplantation. Clin Transpl 1987, 409.
4. Ogura K., Terasaki P.I., Johnson C., Mendez R., Rosenthal J.T., Ettenger R., et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993, 56(2):294.
5. Gebel H.M., Bray R.A., Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003, 3(12):1488.
6. Pei R., Lee J.H., Shih N.J., Chen M., Terasaki P.I. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003, 75(1):43.
7. Dunn T.B., Noreen H., Gillingham K., Maurer D., Ozturk O.G., Pruett T.L., et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant 2011, 11(10):2132.
8. Dunn T., Ozturk G., Nooreen H. Impact of flow XM results on kidney transplant outcomes for recipients with donor specific antibody (DSA). Am J Transplan 2010, 10(Suppl. 4):236. (Abstract).
9. Bartel G., Regele H., Wahrmann M., Huttary N., Exner M., Hörl W.H., et al. Posttransplant HLA alloreactivity in stable kidney transplant recipients-incidences and impact on long-term allograft outcomes. Am J Transplant 2008, 8(12):2652.
10. van den Berg-Loonen E.M., Billen E.V., Voorter C.E., van Heurn L.W., Claas F.H., van Hooff J.P., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008, 85(8):1086.
11. Amico P., Honger G., Mayr M., Steiger J., Hopfer H., Schaub S. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009, 87(11):1681.
12. Gill J.S., Landsberg D., Johnston O., Shapiro R.J., Magil A.B., Wu V., et al. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation 2010, 89(2):178.
13. Solez K., Colvin R.B., Racusen L.C., Haas M., Sis B., Mengel M., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8(4):753.
14. Lee P.C., Zhu L., Terasaki P.I., Everly M.J. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation 2009, 88(4):568.
15. Everly M.J., Rebellato L.M., Ozawa M., Briley K.P., Catrou P.G., Haisch C.E., et al. Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation 2010, 89(8):962.
16. Ren Q., Paramesh A., Yau C.L., Killackey M., Slakey D., Florman S., et al. Long-term outcome of highly sensitized African American patients transplanted with deceased donor kidneys. Transpl Int 2011, 24(3):259.
17. Balasubramaniam G.S., Morris M., Gupta A., Mesa I.R., Thuraisingham R., Ashman N. Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion. Transplantation 2012, 93(4):418-422.
18. Singh N., Djamali A., Lorentzen D., Pirsch J.D., Leverson G., Neidlinger N., et al. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes. Transplantation 2010, 90(10):1079.
19. Burns J.M., Cornell L.D., Perry D.K., Pollinger H.S., Gloor J.M., Kremers W.K., et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008, 8(2):2684.
20. Cai J., Terasaki P.I., Mao Q., Pham T., El-Awar N., Lee J.H., et al. Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant 2006, 6(12):2947.
21. Jacob E.K., De Goey S.R., Gandhi M.J. Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol 2011, 25(1):77.